Skip to main content

Closed

ENTA: Enanta Pharmaceuticals, Inc. Financial Statements & Revenue | finqOS

Healthcare · Biotechnology

52W Range

57thpctl

Volume

0.63×avg

Market Cap

366.39MUSD

P/E Ratio

-4.6TTM

Div Yield

-ann

Enanta Pharmaceuticals, Inc.

ENTANASDAQ Global Select·USD·Closed

Enanta Pharmaceuticals, Inc.

ENTANASDAQ·USD·Closed

$12.60

−3.08%

$12.60

−$0.40 (3.08%)

52W Range

57thpctl

Volume

0.63×avg

Mkt Cap

366.39MUSD

P/E

-4.6TTM

Div Yield

–ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings